Red Pill/Blue Pill Redux. Abbott Board Approves Spin-Off


As we noted here, Abbott Labs is splitting in two.  The board formally approved it and set a December 12 record date for a January 1 dividend date.  Meanwhile, the stock price has not recovered from the body blow delivered by the failure of its kidney/diabetes drug test.  Potentially Opps Tracker candidate?  We’ll take a look.

Abbott Labs Form 8-K

This entry was posted in Opps, Spinoff and tagged , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

3 Responses to Red Pill/Blue Pill Redux. Abbott Board Approves Spin-Off

  1. website seo says:

    This text is worth everyone’s attention. When can I find out more?

  2. JL7Dr says:

    192659 992502Really instructive and superb structure of articles, now that

  3. Thanks for the blog site publish.Thanks Again. Awesome.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>